Relevant bibliographies by topics / Disease prevention

Academic literature on the topic 'Disease prevention'

Author: Grafiati
Published: 4 June 2021
Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Disease prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Disease prevention"

1

Shakhnoza, Iskandarova, and Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 04, no. 04 (April 1, 2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Full text
Abstract:
Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.
APA, Harvard, Vancouver, ISO, and other styles
2

&NA;. "DISEASE PREVENTION." American Journal of Nursing 99, no. 8 (August 1999): 10. http://dx.doi.org/10.1097/00000446-199908000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pignone, Michael P., and Kirsten Bibbins-Domingo. "Disease Prevention." Medical Clinics of North America 101, no. 4 (July 2017): i. http://dx.doi.org/10.1016/s0025-7125(17)30070-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shubrook, Jay H. "Disease prevention." Osteopathic Family Physician 3, no. 5 (September 2011): 181. http://dx.doi.org/10.1016/j.osfp.2011.07.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Selby, JoeV. "DISEASE PREVENTION." Lancet 341, no. 8847 (March 1993): 728–29. http://dx.doi.org/10.1016/0140-6736(93)90493-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

SCHAPIRA, DAVID V. "Disease Prevention." Archives of Internal Medicine 149, no. 6 (June 1, 1989): 1253. http://dx.doi.org/10.1001/archinte.1989.00390060007001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zuo, Tongzhuo. "The Current Status of Occupational Disease Prevention." Learning & Education 9, no. 2 (November 10, 2020): 6. http://dx.doi.org/10.18282/l-e.v9i2.1385.

Full text
Abstract:
Occupational diseases are disorders of health resulting from conditions related to the workplace. There are 2.3 million deaths annually for reasons attributed to work globally, primarily to chemicals or dust. China has the largest working population in the world, with 776 million employed in 2018. According to the National Health Commission, about 12 million companies were found to have occupational-disease-inductive factors and at least 200 million people are exposed to occupational disease hazards. Preventing occupational diseases is a serious worldwide challenge. On the other hand, many developed countries already have rich experience in the prevention and treatment of various occupational diseases. They have set up various occupational disease prevention agencies and formulated strict occupational disease prevention systems. It is necessary for developing countries to learn from their advanced control measures.
APA, Harvard, Vancouver, ISO, and other styles
8

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova, and Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION." UZBEK MEDICAL JOURNAL 2, no. 2 (February 28, 2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Full text
Abstract:
Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").
APA, Harvard, Vancouver, ISO, and other styles
9

Maeda, Kazuo. "Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease." Women Health Care and Issues 2, no. 2 (December 10, 2019): 01. http://dx.doi.org/10.31579/2642-9756/009.

Full text
Abstract:
Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.
APA, Harvard, Vancouver, ISO, and other styles
10

Aslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich, and Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 06 (June 10, 2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.

Full text
Abstract:
Cardiovascular disease is a significant problem that humans have always faced, affecting thousands of people's lives and health and taking the lives of many people. Many medical institutions and researchers have regarded it as a significant problem in overcoming the cardiovascular disease.1 Much attention has been paid, so the prevention and treatment level in this area has also been rapidly improved. However, cardiovascular disease still cannot be prevented or treated fundamentally, and it is still a significant danger to human health. All people still hope for breakthrough results in cardiovascular disease.2 This article analyzes the prevention and treatment of cardiovascular diseases, and has obtained a series of practical and reliable conclusions.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Disease prevention"

1

Baker, J. E. "Ethnicity and cardiovascular disease prevention." Thesis, University of Glasgow, 2015. http://theses.gla.ac.uk/6524/.

Full text
Abstract:
Background Public health interventions need to both improve health and reduce health inequalities, whilst using limited health care resources efficiently. Well-established ethnic differences in cardiovascular disease (CVD) raise the possibility that CVD prevention policies may not work equally well across ethnic groups. The aim of this thesis was to explore whether there are ethnic differences in the potential impact of two CVD prevention policy choices – the choice between mass and targeted screening for high cardiovascular risk, including the use of area deprivation measures to target screening, and the choice between population and high-risk approaches. Methods Cross-sectional data from the Health Survey for England 2003 and 2004 were used. Three sets of analyses were carried out – first, calculation of ethnic differences in the utility of area deprivation measures to identify individual socioeconomic deprivation; second, investigation of ethnic differences in the cost-effectiveness of mass and targeted screening for high cardiovascular risk; third, analysis of ethnic differences in the potential impact of population and high-risk approaches to CVD prevention. Results Area deprivation measures worked relatively effectively and efficiently at identifying individual socioeconomic deprivation in ethnic minority groups compared to the white group. In ethnic groups at high risk of CVD, cardiovascular risk screening programmes were a relatively cost-effective option, screening programmes targeted at deprived areas were particularly cost-effective, and population approaches were found to be an effective and equitable way of preventing CVD despite potential underestimation of their impact. Discussion This thesis found that ethnic minority groups in the UK are unlikely to be systematically disadvantaged by a range of CVD prevention policies that have been proposed, or implemented, for the general population. Additional CVD prevention policies, in particular those based on the population approach, should be implemented.
APA, Harvard, Vancouver, ISO, and other styles
2

Tabatabaei, Ali Reza. "Parkinson's disease : etiology, prevention and treatment." Thesis, University of British Columbia, 1991. http://hdl.handle.net/2429/30382.

Full text
Abstract:
This thesis consists of three chapters dealing with different aspects of Parkinson's disease (PD). 3-Acetylpyridine (3-AP), a naturally occurring neurotoxin, was studied for its neurodegenerative properties on the mesostriatal dopaminergic system in rats as a possible environmental cause of idiopathic PD. Chronic administration of this compound to rats caused a moderate but insignificant reduction of striatal dopamine (determined by HPLC measurement of striatal dopamine) and a more substantial degeneration of cerebellar neurons and their neurotransmitters (determined by amino acid analysis of cerebellum). Prophylactic use of a high dose of nicotinamide prevented the reduction of dopamine in the striatum as well as the severe behavioural manifestations induced by 3-AP in rats. The cerebellar damage, however, was not affected. Different mechanisms of damage by 3-AP in these structures were presumed based on the protective effects of nicotinamide in the substantia nigra but not in the cerebellum. Possible protective properties of MK-801 (a noncompetitive NMDA antagonist) and nicotinamide against MPTP neurotoxicity were also examined in mice. MK-801 treatment provided a substantial protection against MPTP-induced reduction of striatal dopamine. Nicotinamide on the other hand provided no such protection. Finally, a new controversial approach to the treatment of parkinsonism was evaluated. Nervous tissue from 13-15 day-old fetuses was transplanted into MPTP-treated mice. The transplanted material was harvested from different areas of the fetal brain and was prepared by various procedures to examine the possible bases of any improvement in the host animal. After two studies, we did not find a biochemical improvement in transplanted mice treated with MPTP regardless of the nature of the transplanted materials.
Medicine, Faculty of
Anesthesiology, Pharmacology and Therapeutics, Department of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
3

Raafat, Alaeddin. "Rh disease in Scotland : epidemiology and prevention." Thesis, University of Aberdeen, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.409274.

Full text
Abstract:
The first Chapter in this thesis aims to present an adequate background information on the previous work. Short of introducing routine antepartum prophylaxis programme, the only avenues open to impact on the incidence of RhD alloimmunisation, were efforts to fine-tune the operation of the existing postpartum prophylaxis programme.  This included improvement of the accuracy of measuring the volume of transplacental bleeds, in order to ensure that sufficient dose of anti-D is administered to afford protection against sensitisation.  Chapter II discusses the results of a Kleihauer Quality Assurance Scheme in Scotland, and demonstrates that, this scheme was effective in bringing about a change in the practice of Kleihauer testing in Scotland, and introduction of greater standardisation and harmonisation of practice with trends towards improved test results. The data presented in Chapter III, provide data on the incidence of RhD alloimmunisation in Scotland and relate this incidence to similar results obtained using different methodologies and denominators.  These data show that there had been no significant changes in the alloimmunisation rates over the previous decade. Mortality due to Rh disease had been underestimated, due to reliance on registry data.  Combining registry data, information from the case notes of alloimmunised mothers and data from tertiary referral centre in Scotland, as set out in chapter IV demonstrated the true magnitude of fetal / neonatal loss in Scotland between 1987-1991 and provides some information on the long term sequelea of Rh disease.  A total of 20 fetal losses occurred over this period, several fold greater than suggested by the registry data. Finally, in collaboration with Health Economic Research Unit in Aberdeen University, the above information was utilised to assess the economic aspects of introducing routine antenatal prophylaxis.
APA, Harvard, Vancouver, ISO, and other styles
4

Sime, Hazel A. "Disease in sheep flocks and its prevention." Thesis, University of Aberdeen, 1988. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU020968.

Full text
Abstract:
To establish the prevalence of diseases in sheep flocks in North-east Scotland responsive to the application of preventative measures which may be incorporated in flock management plans. A survey of a sample of commercial sheep flocks was carried out to ascertain management and marketing practices. A critical assessment was made of the 'Flock Diary' 'Detailed' and 'Daily' Lambing Diaries produced by the Meat and Livestock Commission and their use. A mastitis survey showed an overall incidence for acute severe and chronic mild mastitis of 1.5% and 4.2% respectively. Orf was a particularly important predisposing factor. Antibiotic therapy at weaning resulted in a reduction in the number of ewes culled for chronic mastitis but growth rate of subsequent lambs was unaffected. A survey of trace element status of flocks showed that deficiencies were not always recognised especially selenium. On-farm trials were set up to examine the implications of copper, cobalt and selenium deficiencies and possible methods of control and monitoring. Trials of these procedures in commercial flocks included measurements of blood composition, ewe body condition score, lambing data, lamb birth weight and early growth rate. In lamb based trials blood composition and growth rate were the only parameters measured. Trials over a 4 week period were carried out to test the effectiveness of selenium-cobalt supplemented anthelminthics. The cobalt content of such products was inadequate to maintain pre-existing cobalt/vitamin B12 status in weaned lambs, however, selenium content induced a sustained rise in selenium/GSH-Px. Treatment with oxytetracycline reduced the number of chlamydial abortions in vaccinated gimmers while selenium treatment reduced the stillbirth rate. There was a suggestion that a compliment fixation titre of 1/16 was indicative of infection. Factors limiting implementation of preventive measures in flocks were the absence of performance and health records, accurate diagnosis, effective communication between farmers and external agencies and sources of integrated advice.
APA, Harvard, Vancouver, ISO, and other styles
5

Frauenberg, Sarah. "Aspirin Use for Primary Prevention of Cardiovascular Disease." Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/29207.

Full text
Abstract:
Cardiovascular disease (CVD) is a major cause of morbidity and mortality in the United States and aspirin is a well-known medication strongly associated with CVD prevention. Aspirin has undeniable benefits in the role of secondary prevention of CVD, however, the benefits are ambiguous when associated with primary prevention. The decision to start aspirin for primary prevention becomes complicated due to aspirin?s effect on coagulation and the risk of gastric ulceration. The United States Preventive Services Task Force (USPSTF) has level B recommendations in place regarding the use of low-dose aspirin (81 mg) for primary prevention of CVD. In addition, the American Heart Association (AHA) and American College of Cardiology (ACC) developed a calculator in 2013 to determine a patient?s 10-year CVD risk. The guideline and CVD calculator offer healthcare providers an easy-to-navigate tool to determine proper patient use of aspirin. However, despite the USPSTF guideline, appropriate aspirin use remains suboptimal. Successful adoption of the 2016 USPSTF guideline on aspirin use for primary prevention of CVD by providers in two rural North Dakota communities was the goal of this practice improvement project. The project began with education to providers and staff at the rural clinics regarding the USPSTF guideline and the ACC/AHA calculator. Following the educational session, implementation of the USPSTF guideline occurred for three months. Evaluation was performed through the use of a post-implementation survey. Results of the project demonstrated increased knowledge and usage of the guideline and a positive viewpoint related to implementation of the guideline with the providers in both of the communities having plans to sustain use in future practice. Data were also collected at a health screening fair in one of the rural communities to validate whether patients were taking aspirin per USPSTF guideline. Data gathered from the fair concluded only 59% of patients (41 out of 70) were taking, or not taking, aspirin appropriately according to the USPSTF guideline. Conclusively, primary care providers would be well served by using the ACC/AHA calculator and 2016 USPSTF guideline with all patients 40-79 years of age to determine appropriate use of aspirin for primary prevention of CVD.
APA, Harvard, Vancouver, ISO, and other styles
6

IJzerman, E. P. F. "Progress in diagnostics and prevention of Legionnaires' disease." [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2009. http://irs.ub.rug.nl/ppn/315954442.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Basu, Rashmita. "Healthy lifestyle, disease prevention and health care utilization." Pullman, Wash. : Washington State University, 2009. http://www.dissertations.wsu.edu/Dissertations/Fall2009/r_basu_112309.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Neubeck, Alicia Helen. "Increasing access to secondary prevention of cardiovascular disease." Thesis, The University of Sydney, 2011. https://hdl.handle.net/2123/27329.

Full text
Abstract:
Background: Access to secondary prevention remains disconcertingly low despite proven benefits. The objectives of this thesis were: to evaluate telehealth models of secondary prevention; to determine barriers to participation in secondary prevention; to evaluate the long-term outcomes of a previously proven telehealth model, CHOICE (Choice of Health Options In prevention of Cardiovascular Events); to determine the replicability and generalisability of CHOICE; and to determine future directions for delivery of secondary prevention. Methods: Mixed methods were utilised to achieve the objectives of this thesis. To evaluate telehealth models, a systematic review and meta-analysis process was followed. To determine the barriers to participation in secondary prevention, a systematic review and meta-synthesis process was followed; to evaluate the long-term outcomes of CHOICE, patients who had participated in the original single centre trial had a repeat assessment at four-years after their baseline assessment; to determine the replicability and generalisability of CHOICE, a multi-centre replication trial involving 270 participants was conducted; and to determine future directions for delivery of SP, both quantitative and qualitative methods, including survey and focus groups, were undertaken. Results: Telehealth based models of secondary prevention can improve access, reduce risk factors and improve quality of life in patients who do not participate in facility-based secondary prevention programs. While there are a number of barriers to participation in facility-based secondary prevention, some of which are potentially modifiable, it was clear from our review that a one-size fits all approach will not be suitable and telehealth models can provide additional options for access to secondary prevention. Results of the long-term follow-up of the single centre trial demonstrated that at four years participants in CHOICE had maintained the significant improvements that they had made at one year. In the current replication study results showed that participants were at lower baseline risk than in the previous single-centre study, but still made improvements in multiple cardiovascular risk factors. Finally, we determined that an Internet-based model of secondary prevention would suit some, but not all, patients with cardiovascular disease and may provide an additional option for patients not accessing facility-based programs Conclusion: There are multiple barriers to the uptake of secondary prevention and telehealth models can offer an evidence-based alternative to patients who do not access facility-based programs. The CHOICE program is a flexible telehealth model that provides long-term behaviour change and is readily translated into multiple clinical settings. Future work could focus on utilising new technology to increase uptake to proven secondary prevention models such as CHOICE.
APA, Harvard, Vancouver, ISO, and other styles
9

Wahjoepramono, Eka J. "Role of testosterone in prevention of Alzheimer's Disease." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2012. https://ro.ecu.edu.au/theses/518.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Waitayakul, Chittaya. "Effectiveness of the life skills program for HIV/AIDS prevention in Northern Thai housewives." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2006. https://ro.ecu.edu.au/theses/342.

Full text
Abstract:
This research has applied a Life Skills Program to the health area of HIV/AIDS. The study included both qualitative and quantitative analyses especially designed to establish a strategy to prevent and control HIV/AIDS infection in Thailand. A pseudo-experimental research design was used with pre-test/post-test questionnaires and interviews. The lack of HIV/AIDS knowledge among Thai people and unsafe sexual behaviours place them at risk of acquiring HIV and AIDS. Thus, there is a need to construct a strategy to prevent and reduce the high risk behaviours associated with this infection. The study targeted housewives between the ages of 15 and 60 years living in urban and rural low-income areas in Nakhon Sawan Province in the south of the northern region of Thailand. One hundred housewives participated in the program.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Disease prevention"

1

Stang, Lucas. Disease prevention. Santa Cruz, Calif: ETR Associates, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wood, David. Cardiovascular disease prevention. London: Mosby, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Washington (State). Dept. of Health., ed. Chronic disease prevention. Olympia, Wash: The Department, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

S, Garewal Harinder, ed. Antioxidants and disease prevention. Boca Raton: CRC Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Allman, Toney. Nutrition and Disease Prevention. New York: Infobase Pub., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

G, Yanowitz Frank, ed. Coronary heart disease prevention. New York: Dekker, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Allman, Toney. Nutrition and disease prevention. New York: Chelsea House, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

H, Friedlaender Mitchell, and Alta California Eye Research Foundation., eds. Prevention of eye disease. New York, NY: Mary Ann Liebert Inc., 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Warner, Hudson T., ed. Clinical preventive medicine: Health promotion and disease prevention. Boston: Little, Brown, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

J, Murray John, ed. The Prevention of dental disease. 2nd ed. Oxford: Oxford University Press, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Disease prevention"

1

Lee, Sungnack, Dongsik Bang, Eun-So Lee, and Seonghyang Sohn. "Prevention." In Behçet’s Disease, 73. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56455-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lee, Nanette V. L., and John P. Elder. "Disease Prevention." In Encyclopedia of Immigrant Health, 556–62. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5659-0_214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ernst, Edzard. "Disease Prevention." In Chiropractic, 131–35. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-53118-8_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Caplan, Ronald M. "Disease Prevention." In Long Life Strategy, 31–36. Cham: Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-44518-7_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Laverack, Glenn. "Disease Prevention." In A–Z of Health Promotion, 50–53. London: Macmillan Education UK, 2014. http://dx.doi.org/10.1007/978-1-137-35049-7_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Singh, Hari. "Disease Prevention." In Public Health, 65–67. New York: Productivity Press, 2024. http://dx.doi.org/10.4324/9781032644257-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Prince, Alfred M., and Kusuya Nishioka. "Prevention." In Viral Hepatitis and Liver Disease, 499–500. Tokyo: Springer Japan, 1994. http://dx.doi.org/10.1007/978-4-431-68255-4_127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Marin-Neto, José Antonio, Anis Rassi, Andréa Silvestre de Sousa, João Carlos Pinto Dias, and Anis Rassi. "Chagas Disease: A Neglected Disease." In Prevention of Cardiovascular Diseases, 159–82. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Paharia, M. Indira. "Chronic Disease Prevention." In Comprehensive Handbook of Clinical Health Psychology, 53–80. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118269657.ch3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hooker, Stephanie Ann. "Cardiovascular Disease Prevention." In Encyclopedia of Behavioral Medicine, 377–80. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_1611.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Disease prevention"

1

Maleki, Samira, and Nasser Jazdi-Motlagh. "An AI-based Assistance System for Determining the Risk of Disease and for Preventive Measures." In Human Systems Engineering and Design (IHSED 2021) Future Trends and Applications. AHFE International, 2021. http://dx.doi.org/10.54941/ahfe1001102.

Full text
Abstract:
Prevention of widespread diseases can make an important contribution to improving the quality of human life. Furthermore, disease prevention can serve to avoid future demands for medical rehabilitation due to demographic change. In this paper, a literature review on the state of the art in disease prevention through machine learning will be presented first. Subsequently, it was concluded that no previous applications have focused on determining the extent of the influencing factors on the risk of disease and thus identifying preventive measures to reduce the risk of disease. To address this research gap, this paper presents a concept for generating a personalized prediction model for a given disease, using machine learning algorithms for the automated analysis of a wide range of input data. To realize this concept, an assistance system is implemented be presented, which includes prediction models for the three diseases cold, hypertension and hypercholesterolemia to determine disease risks and preventive measures. After entering the user's health data, the assistance system determines the risk for each disease and the preventive measures to reduce the disease risks. Thereafter, the evaluation of the assistance system is presented by testing it on 5 people who used it daily for 4 months.
APA, Harvard, Vancouver, ISO, and other styles
2

Gaidhane, Triveni, Shraddha Shinde, Nilesh Aurade, and Usha Verma. "Smart Disease Prevention System." In 2022 Fourth International Conference on Emerging Research in Electronics, Computer Science and Technology (ICERECT). IEEE, 2022. http://dx.doi.org/10.1109/icerect56837.2022.10060650.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gajowniczek-Ałasa, Dorota, Ewa Baranowska-Wójcik, and Dominik Szwajgier. "Food in Alzheimer’s disease prevention." In 2nd International PhD Student’s Conference at the University of Life Sciences in Lublin, Poland: ENVIRONMENT – PLANT – ANIMAL – PRODUCT. Publishing House of The University of Life Sciences in Lublin, 2023. http://dx.doi.org/10.24326/icdsupl2b004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Esina, Е. Y., A. A. Zuykova, N. V. Strachova, V. V. Lyutov, and V. N. Tsigan. "Unresolved Cardiovascular Disease Prevention Issues." In Proceedings of the International Conference on Health and Well-Being in Modern Society (ICHW 2019). Paris, France: Atlantis Press, 2019. http://dx.doi.org/10.2991/ichw-19.2019.24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Allegretti, Jessica, and Karin Drooff. "Oral microbes effective for prevention of recurrent Clostridium difficile infections." In Digestive Disease Week 2022, edited by Rachel Giles. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/4995cbe9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Purtskhvanidze, V. A., O. A. Orlovtseva, S. N. Tefikova, and M. V. Klokonos. "Algorithms For Preventive Measures For Disease Prevention And Antioxidant Protection." In International Scientific and Practical Conference "Biotechnology, Ecology, Nature Management". European Publisher, 2022. http://dx.doi.org/10.15405/epls.22011.30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Guillen, Sergio G., Pilar Sala, Joerg Habetha, Ralf Schmidt, and Maria-Teresa Arredondo. "Innovative Concepts for Prevention and Disease Management of Cardiovascular Diseases." In Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.259449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guillen, Sergio G., Pilar Sala, Joerg Habetha, Ralf Schmidt, and Maria-Teresa Arredondo. "Innovative Concepts for Prevention and Disease Management of Cardiovascular Diseases." In Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.4397420.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

WANG, Jun, and Yan ZHAO. "Astaxanthin in Disease Prevention and Treatment." In 2nd International Conference on Biomedical and Biological Engineering 2017 (BBE 2017). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/bbe-17.2017.67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kaipainen, Kirsikka, Anita Honka, and Niilo Saranummi. "Personalized behavior change support for disease prevention." In 2011 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2011. http://dx.doi.org/10.1109/iembs.2011.6090196.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Disease prevention"

1

Lee, S. Chronic Beryllium Disease Prevention Program Report. Office of Scientific and Technical Information (OSTI), March 2012. http://dx.doi.org/10.2172/1047244.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Storb, Rainer. Prevention of Canine Graft-versus-Host Disease (GVHD). Fort Belvoir, VA: Defense Technical Information Center, November 1986. http://dx.doi.org/10.21236/ada184469.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lee, S. LLNL Chronic Beryllium Disease Prevention Program 10 CFR 850 Requirements Flowdown. Office of Scientific and Technical Information (OSTI), January 2012. http://dx.doi.org/10.2172/1034488.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

McLaughlin, Gayla D. Barriers To Health Promotion And Disease Prevention Within The Military Healthcare System. Fort Belvoir, VA: Defense Technical Information Center, April 1999. http://dx.doi.org/10.21236/ad1012156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wang, Li Fang, Yan Ting Cao, Tegeleqi Bu, Lin Fu, Jun Li Liu, and Jing Zhao. Do We Receive Cytomegalovirus Vaccination Before Solid Organ Transplant: a Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0143.

Full text
Abstract:
Review question / Objective: We compared cytomegalovirus (CMV) vaccination for solid organ transplantation recipients ( SOTs) with placebo treatment, to investigate the efficacy and safety for the prevention of CMV infection in SOTs. Condition being studied: Patients after solid organ transplantation subsequently become immunosuppressed, and cytomegalovirus (CMV) is the most common opportunistic pathogen to this population. The prevalence of CMV infection can reach 50% in the general population, and further up to 64-72% in solid organ transplant recipients (SOTs). CMV seropositive donors (CMV D+) puts even more pressure of CMV infection for SOTs. Post-transplant CMV infection can lead to neutropenia, lymphopenia, thrombocytopenia, tissue/end-organ invasive CMV disease (gastroenteritis, pneumonia, hepatitis, encephalitis), other infectious diseases, graft dysfunction, and multiple organ failure. CMV can disturb immune cell function, thus is one of the major risk factors that increase mortality within 6 months after transplantation. However, practical, effective method to prevent postoperative CMV infection for SOTs remains unresolved. Vaccination of CMV is only at clinical trials stage. To date, there is a lack of guidelines or consensus for preventing CMV disease for SOTs. Given the increasing clinical trials of CMV vaccination, it is important to clarify the evidence-based benefits and risks of CMV vaccination for SOTs, and to provide the best CMV disease prevention measurements.
APA, Harvard, Vancouver, ISO, and other styles
6

Brungardt, Rachel. SGLT2 Inhibitor Dapagliflozin and Its Effects on the Body in the Treatment and Prevention of Diabetes, Chronic Renal Disease, and Cardiovascular Disease. Ames (Iowa): Iowa State University, May 2022. http://dx.doi.org/10.31274/cc-20240624-1279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wells, Robert. Role of Melatonin in the Prevention of Breast Cancer in Patients with Cystic Breast Disease. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada403645.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Askin, A., B. Buddemeier, M. Alai, and K. Yu. Centers for Disease Control and Prevention (CDC) Radiation Hazard Scale Data Product Review Feedback Report. Office of Scientific and Technical Information (OSTI), September 2017. http://dx.doi.org/10.2172/1399754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wells, Robert L. Role of Melatonin in the Prevention of Breast Cancer in Patients With Cystic Breast Disease. Fort Belvoir, VA: Defense Technical Information Center, September 2003. http://dx.doi.org/10.21236/ada424033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wells, Robert L. Role of Melatonin in the Prevention of Breast Cancer in Patients With Cystic Breast Disease. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada392483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Disease prevention' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography